1,707
edits
Line 40: | Line 40: | ||
:*Institute a screening process to identify patients who are latex sensitive. The screening process includes the use of the [http://unmc.edu/policy/index.cfm?L1_ID=18&L2_ID=20&CONREF=85 Latex Sensitivity Screening Questionnaire for Patients]. | :*Institute a screening process to identify patients who are latex sensitive. The screening process includes the use of the [http://unmc.edu/policy/index.cfm?L1_ID=18&L2_ID=20&CONREF=85 Latex Sensitivity Screening Questionnaire for Patients]. | ||
:*Implement procedures to minimize risk to latex sensitive patients. | :*Implement procedures to minimize risk to latex sensitive patients. | ||
:*Develop a method to alert staff, on an ongoing basis, regarding patients with latex sensitivity/allergy or those identified as being in a [[#Risk_Groups|high risk]] group for latex allergy. | :*Develop a method to alert staff, on an ongoing basis, regarding patients with latex sensitivity/allergy or those identified as being in a [[#Risk_Groups|high risk]] group for latex allergy. | ||
:*Assess the environment to identify products and equipment containing latex and identify alternative products and equipment. | :*Assess the environment to identify products and equipment containing latex and identify alternative products and equipment. | ||
*Patients with a known allergic response to latex exposure or identified as being in a [[#Risk_Groups|high risk]] group for latex allergy shall be placed on "Latex Precautions." | *Patients with a known allergic response to latex exposure or identified as being in a [[#Risk_Groups|high risk]] group for latex allergy shall be placed on "Latex Precautions." |